MTOR and neoplasm: Activation of the mTOR pathway has been linked to tumor growth and its inhibitors are currently used in clinical trials for cancer patients.33 Since AKAP1 is critical for mTORC1 activation, we predicted that the anchor protein supports tumor cell growth.